Assessment of efficacy and tolerability of elexacaftor-tezacaftor-ivacaftor in an observational cohort study of "aged" people with cystic fibrosis.

Saved in:
Bibliographic Details
Title: Assessment of efficacy and tolerability of elexacaftor-tezacaftor-ivacaftor in an observational cohort study of "aged" people with cystic fibrosis.
Authors: Blankenship S; Division of Internal Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA., Flueckiger BV; Division of Internal Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA., Caleb G; Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA., Bailey J; Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA., Baker E; Department of Anesthesiology, The University of Alabama at Birmingham, Birmingham, AL, USA.; Gregory Fleming James Cystic Fibrosis Research Center, The University of Alabama at Birmingham, Birmingham, AL, USA., Garcia B; Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.; Gregory Fleming James Cystic Fibrosis Research Center, The University of Alabama at Birmingham, Birmingham, AL, USA., Krick S; Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The University of Alabama at Birmingham, THT422, 1900 University Boulevard, Birmingham, AL 35294, USA.; Gregory Fleming James Cystic Fibrosis Research Center, The University of Alabama at Birmingham, Birmingham, AL, USA.
Source: Therapeutic advances in respiratory disease [Ther Adv Respir Dis] 2026 Jan-Dec; Vol. 20, pp. 17534666251410246. Date of Electronic Publication: 2026 Jan 02.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 101316317 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1753-4666 (Electronic) Linking ISSN: 17534658 NLM ISO Abbreviation: Ther Adv Respir Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41482647
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Assessment of efficacy and tolerability of elexacaftor-tezacaftor-ivacaftor in an observational cohort study of "aged" people with cystic fibrosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Blankenship+S%22">Blankenship S</searchLink>; Division of Internal Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Flueckiger+BV%22">Flueckiger BV</searchLink>; Division of Internal Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Caleb+G%22">Caleb G</searchLink>; Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Bailey+J%22">Bailey J</searchLink>; Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Baker+E%22">Baker E</searchLink>; Department of Anesthesiology, The University of Alabama at Birmingham, Birmingham, AL, USA.; Gregory Fleming James Cystic Fibrosis Research Center, The University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Garcia+B%22">Garcia B</searchLink>; Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.; Gregory Fleming James Cystic Fibrosis Research Center, The University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Krick+S%22">Krick S</searchLink>; Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, The University of Alabama at Birmingham, THT422, 1900 University Boulevard, Birmingham, AL 35294, USA.; Gregory Fleming James Cystic Fibrosis Research Center, The University of Alabama at Birmingham, Birmingham, AL, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101316317%22">Therapeutic advances in respiratory disease</searchLink> [Ther Adv Respir Dis] 2026 Jan-Dec; Vol. 20, pp. 17534666251410246. <i>Date of Electronic Publication: </i>2026 Jan 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101316317 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1753-4666 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217534658%22">17534658 </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Respir Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41482647
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/17534666251410246
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 17534666251410246
    Titles:
      – TitleFull: Assessment of efficacy and tolerability of elexacaftor-tezacaftor-ivacaftor in an observational cohort study of "aged" people with cystic fibrosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Blankenship S
      – PersonEntity:
          Name:
            NameFull: Flueckiger BV
      – PersonEntity:
          Name:
            NameFull: Caleb G
      – PersonEntity:
          Name:
            NameFull: Bailey J
      – PersonEntity:
          Name:
            NameFull: Baker E
      – PersonEntity:
          Name:
            NameFull: Garcia B
      – PersonEntity:
          Name:
            NameFull: Krick S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan-Dec
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1753-4666
          Numbering:
            – Type: volume
              Value: 20
          Titles:
            – TitleFull: Therapeutic advances in respiratory disease
              Type: main
ResultId 1